Separate FDA Post-Market Drug Safety Office Outlined In Approps Bill Report
This article was originally published in The Pink Sheet Daily
Executive Summary
House subcommittee would provide FDA with $55 million more than the amount requested in President Obama's FY 2011 budget proposal.
You may also be interested in...
Separate FDA Safety Office Attached To House Report, Still Faces Steep Road
A proposal to establish an independent post-market drug surveillance office at FDA will face tough sledding if it comes up in the House Energy and Commerce Health Subcommittee.
Separate FDA Safety Office Attached To House Report, Still Faces Steep Road
A proposal to establish an independent post-market drug surveillance office at FDA will face tough sledding if it comes up in the House Energy and Commerce Health Subcommittee.
FDA Expects Sharp Drop In Fee-Paying Drug Applications This Year
In what could be viewed as an ominous sign of declining pharmaceutical R&D productivity, FDA is predicting a sharp drop-off in fee-paying drug and biologic applications in the current fiscal year